Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/121342
Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: To evaluate barrier protective properties of Rhinosectan® spray, a medical device containing xyloglucan, on nasal epithelial cells (MucilAir). Methods: MucilAir-Nasal, a three-dimensional organotypic (with diferent cell types) airway tissue model, was treated with the medical device Rhinosectan® (30 µL) or with controls (Rhinocort budesonide or saline solution). The protective barrier efects of Rhinosectan® were evaluated by: TEER (trans-epithelial electrical resistance) (preservation of tight junctions), Lucifer Yellow assay (preservation of paracellular fux) and confocal immunofuorescence microscopy (localization of tight junction proteins). Results: Exposure of MucilAir with Rhinosectan® protected cell tight junctions (increases in TEER of 13.1% vs −6.3% with saline solution after 1 h of exposure), and preserved the paracellular fux, even after exposure with pro-infammatory compounds (TNF-α and LPS from Pseudomonas aeruginosa 10). Results of confocal immunofuorescence microscopy demonstrated that, after treatment with the pro-infammatory mixture, Rhinosectan® produced a slight relocation of zona occludens-1 in the cytosol compartment (while Rhinocort induced expression of zona-occludens-1), maintaining the localization of occludin (similarly to negative control). Conclusions: Results of our study indicates that Rhinosectan® creates a protective physical barrier on nasal epithelial cells in vitro, allowing the avoidance of allergens and triggering factors, thus confrming the utility of this medical device in the management of nasal respiratory diseases, as rhinitis or rhinosinusitis. Keywords: Nasal obstruction, Rhinitis, Rhinosinusitis, Orgatypic 3D airway tissue model (MucilAir), Rhinosectan®, Xyloglucan, Barrier properties, Allergy, Preventive measures
Matèries
Matèries (anglès)
Citació
Citació
DE SERVI, Barbara, RANZINI, Francesco, PIQUÉ I CLUSELLA, Núria. Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.. _Allergy_. Asthma and Clinical Immunology. Vol. 2017, núm. 13, pàgs. 37. [consulta: 24 de gener de 2026]. ISSN: 1710-1492. [Disponible a: https://hdl.handle.net/2445/121342]